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Edited by Miguel De la RosaAbstract An essential diﬀerence between eukaryotic ferritins
and bacterioferritins is that the latter contain naturally, in vivo
haem as Fe-protoporphyrin IX. This haem is located in a hydro-
phobic pocket along the 2-fold symmetry axes and is liganded by
two Met 52.
However, in in vivo studies, a cofactor has been isolated in
horse spleen apoferritin similar to protoporphyrin IX; in
in vitro experiments, it has been shown that horse spleen apofer-
ritin is able to interact with haem. Studies of haemin (Fe(III)-
PPIX) incorporation into horse spleen apoferritin have been
carried out, which show that the metal free porphyrin is found
in a corresponding pocket to haem in bacterioferritins [Pre´ci-
goux, G., Yariv, J., Gallois, B., Dautant, A., Courseille, C.
and Langlois, d’Estaintot B. (1994) A crystallographic study
of haem binding to ferritin. Acta Cryst. D 50, 739–743].
A mechanism of demetallation of haemin by L-chain apoferri-
tin was proposed [Crichton, R.R., Soruco, J.A., Roland, F.,
Michaux, M.A., Gallois, B., Pre´cigoux, G., Mahy, J.P. and
Mansuy. (1997) Remarkable ability of horse spleen apoferritin
to demetallate hemin and to metallate protoporphyrin IX as a
function of pH. J. P. Biochem. 36, 49, 15049–15054]: this in-
volved four Glu residues (53,56,57,60) situated at the entrance
of the hydrophobic pocket and appeared to be favoured by acidic
conditions.
To verify this mechanism, we have mutated these four Glu to
Gln and examined demetallation in both acidic and basic condi-
tions.
In this paper, we report the mass spectrometry studies of L-
chain apoferritin and its mutant incubated with haemin and ana-
lysed after diﬀerent times of incubation: 15 days, 2 months, 6
months, 9 months and 12 months. These studies show that the re-
combinant L-chain apoferritin and its mutant are able to demet-
allate haemin to give a hydroxyethyl protoporphyrin IX
derivative in a dimeric form [Macieira, S., Martins, B. M. and
Huber, R. (2003) Oxygen-dependent coproporphyrinogen IX
oxidase from Escherichia coli: one-step puriﬁcation and bio-
chemical characterization. FEMS. Microbiology Letters 226,
31–37].
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Iron, element 26 in the periodic table, is the second most
abundant metal (after aluminium), and the fourth most abun-
dant element in the Earth’s crust [1]. It is an essential bio-
element which participates in many biological systems in
mammals, plants and bacteria.
Most of the iron present in living organisms is complexed in
proteins, although it may also be present in a soluble pool of
low molecular weight complexes [2]. Uncomplexed iron to-
gether with superoxide (which reduces Fe(III), {1}) and hydro-
gen peroxide (which is decomposed by the Fenton reaction,
{2}) [3] provides a lethal mixture generating reactive hydroxyl
radicals. The sum of these reactions is the Haber–Weiss reac-
tion {3} [4]
Fe3þ þO2 ! Fe2þ þO2 ð1Þ
Fe2þ þH2O2 ! Fe3þ þOH þOH ð2Þ
O2 þH2O2 ! OH þOH þO2 ð3Þ
The hydroxyl radical is very reactive causing lipid peroxida-
tion, DNA and protein damage and degradation of other bio-
molecules [5].
Sequestration of iron in a soluble, bioavailable and non-
toxic form is achieved by iron storage in proteins, ferritins
and bacterioferritins, which are widely distributed throughout
in living kingdom. Diﬀerent kinds of ferritins have been iso-
lated from vertebrates, invertebrates, ﬂowering plants, fungi
and bacteria. They can be classiﬁed into ferritins containing
only non-haem iron, like mammalian, plant and certain bacte-
rial ferritins, and on the other hand, bacterioferritins contain-
ing both non-haem and haem-iron (bacterioferritins in E. coli,
A. vinalendii, etc.). There is an extensive structural homology
between all these ferritins (molecular weight, amino acid com-
position, isoelectric point, size, tertiary and quaternary struc-
ture) [1,6].
Ferritins are tetracosameric protein shells (24-mers) with
their subunits packed in 432 symmetry, each of molecular
weight around 20 kDa, forming a hollow protein shell of
nearly 80 A˚ in diameter. The tetracosamers of molecular
weights ranging from 450 to 500 kDa, and are capable of stor-
ing up to a maximum of 4500 Fe(III) atoms as an inorganic
oxyhydroxide complex, which in mammalian ferritins ressem-
bles the biomineral ferrihydrite [7] (see Fig. 1).
Mammalian ferritins contain two subunit types, H and L
[8,9], which despite extensive diﬀerences in their amino acid
sequences have essentially identical tertiary conformations,blished by Elsevier B.V. All rights reserved.
Fig. 1. (a) Overview of a ferritin molecule showing the relative positions and interfaces between symmetry related subunits. (b) Labelling scheme of
symmetry related subunits. (c) Detail of a single ferritin subunit [16].
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(A, B, C and D) form a compact four helical bundle. The
last short helix E is placed almost perpendicular to the other
four a helices. The four long helices (A, B, C and D) form
a tight bundle which does not have a uniformly hydropho-
bic interior. B and D helices are placed at the interior of
the protein shell whereas A and C are turned towards the
external surface of the tetracosameric molecule [7]. Follow-
ing the Drysdale model, the two types of subunits can form
25 diﬀerent heteropolymers [10]. Each tissue contains
molecules with compositions in H:L ratios which are sensi-
tive to tissue iron loading, this usually causes a relative
increase in L subunits; whereas, heart, brain and also red cell
ferritin are generally H-chain rich [11]. In contrast most
bacterial ferritins are generally composed of a single subunit
type.
H-chains catalyse the oxidation of Fe(II) to Fe(III)
(ferroxidase activity) and the functional importance of L-
chains is thought to reside primarily in their ability to promote
ferrihydrite nucleation; it has been demonstrated that these
two chains have co-operative roles in iron mobilisation [12–
15].
We report here a mass spectrometry study of the demetalla-
tion of haemin by recombinant horse L-chain apoferritin and
its mutant (E 53,56,57,60 Q) in acidic and basic conditions
after diﬀerent times of incubation with haemin at stable tem-
perature.2. Materials and methods
2.1. Materials
The material use to prepare the recombinant L-chain apoferritin and
its mutant (E 53,56,57,60 Q) before incorporation of haemin are: Hae-
min Chloride Bovine (Sigma–Aldrich, St. Louis, USA), NaN3 (Merck,
Darmstadt, Germany), Casein hydrolysate (Merck, Darmstadt, Ger-
many), Yeast extract (Merck, Darmstadt, Germany), NaCl (Fisher Sci-
entiﬁc, London, UK), Ammonium sulphate (Acros Organics, New
Jersey, USA), TRIS ultrapure (Applichem Biochemica, Darmstadt,
Germany), Sephacryl S-300 (Pharmacia, Uppsala, Sweden), Thiogly-
colic acid (Acros Organics, New Jersey, USA), NaOH (Merck, Darms-
tadt, Germany), NH4HCO3 (Merck, Darmstadt, Germany) Pyridine
(Fluka Chemika), Acetic acid glacial (Fisher Scientiﬁc, London,
UK), Bradford (Biorad, Mu¨nchen, Germany), Dialysis membrane
(Medicell International, Ltd, London, UK) and microconcentrators
(Vivapore 5 ml, Vivascience, Sartorius group).2.2. Methods
1. Expression of recombinant horse L-chain ferritin and its
mutant (E 53,56,57,60 Q):
The E. coli strain BMH-71-18 was transformed with the plasmid
pMK2100 which is the fusion of the cDNA coding for horse L-chain
ferritin and a vector pTZ18U. This expression vector controls the
expression of the ferritin gene with a promoter tac which is present to-
gether with the Ampr gene in the same plasmid [17].
A bacterial colony containing the appropriate plasmid or 30 ll of the
bacterial solution conserved in glycerol at 80 C was incubated in
70 ml of 2· TY-Amp medium and left shaking at 37 C overnight.
Afterwards, 50 ml of the resulting culture was incubated in 250 ml of
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phase, the culture was kept in an ice bath for 10 min, centrifuged at
10000 rpm for 25 min, resuspended in a solution of NaN3 0.02% (w/
v) and stored at 20 C.
2. Puriﬁcation of recombinant horse L-chain ferritin and its mutant (E
53,56,57,60 Q):
The bacterial cells were lysed by sonication on ice. The supernatant,
after centrifugation at 10000 rpm for 30 min, was subjected to a ther-
mal denaturation step at 65C for 10 min in a shaking water bath.
After centrifugation at 15000 rpm for 20 min, the supernatant under-
went ammonium sulphate precipitation (56% w/v) at 4 C, and the pel-
let, after centrifugation at 15000 rpm for 15 min was resuspended in a
minimal volume of 25 mM Tris–HCl buﬀer, pH 7.5, and dialysed
against the same buﬀer during 24 h. Thereafter, the ﬁnal step in the
puriﬁcation involved chromatography on Sephacryl S-300.
3. Apoferritin preparation:
Apoferritin was prepared from recombinant L-chain ferritin and its
mutant by dialysing against 0.5% (v/v) thioglycolic acid, pH adusted to
5.5 with NaOH 6 M, for 24 h at room temperature [18]. The excess of
thioglycolic acid was removed by dialysing against ammonium bicar-
bonate 0.5% (w/v) for 24–48 h. After this time, the apoferritin was dia-
lysed against the appropriate buﬀer before use. In our case, the two
buﬀers used were: C7H9NO2 0.1 M, pH 5, and NH4HCO3 0.1 M, pH 8.
4. Concentration of recombinant horse L-chain apoferritin and its mu-
tant (E 53,56,57,60 Q) and incubation with haemin:
After determination of the protein concentration by the Bradford re-
agent [19] the protein was concentrated from 0.5 to 10–20 mg/ml with
the Vivapore method 5 ml concentrator (Vivascience, Sartorius
Group). After the concentration, the protein was incubated with
12 mol of haemin per molecule of apoferritin ( haemin was dissolved
in NH4HCO3 0.1 M buﬀer to have a stock concentration of 8 mM).
5. Mass spectrometry:
Electrospray ionization (ESI) mass spectra in positive mode were ac-
quired on a time of ﬂight mass spectrometer (microTof, Bruker Dal-
tonics, Bremen, Germany). The instrument was calibrated using a
solution of horse heart myoglobin 2 lmol/l in water/acetonitrile 50/
50 (v/v), 1% HCOOH. The ESI-source was heated to 200 C.
Sample solutions (concentration 2 lM) were introduced into the
mass spectrometer source with a syringe pump (Cole Parmer, Vernon
Hills, Illinois, USA) with a ﬂow rate of 5 ll/min. Scanning was per-
formed on a m/z range from 50 to 3000, data were averaged for
1 min and then smoothed using the Gaussian algorithm.
ESI-MS spectrum of native ferritin in non-denaturating conditions
was acquired on an Q-TOF II instrument (Waters, Massachusetts,
USA). Prior to mass spectrometry experiments, non-volatile salts400 600
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Fig. 2. Control experiment with haemin in CH3CN/H20 (50/50 v/v) + 1%HC
spectrum; (b) fresh solution; (c) solution stocked at room temperature for 4 m
isotopic proﬁles.were removed by exchanging the puriﬁcation buﬀer of samples
against ammonium acetate (50 mM, pH 7) using Vivaspin microcon-
centrators (Vivasciences). Ammonium acetate buﬀer is compatible
with both the complex stability and ESI-MS analysis. Samples were
continuously infused into the ESI source at a ﬂow rate 5 ll/min, and
data averaged for 10 min. The atmospheric pressure/vacuum inter-
face parameters were chosen to ensure that the non-covalent interac-
tion can survive the ionization/desorption process. In particular,
high pressure in the interface (7 mbar) for good transmission of
large m/z ions and high cone voltage (200 V) for good desolvation
were required.
Calibration was performed using the ions from multiply charged
clusters of CsI on a m/z range from 2000 to 16000.3. Results
3.1. Control experiments
Several control experiments were conducted in order to be
sure that the protein has some inﬂuence on haemin; with these
control experiments, we have demonstrated that the signal of
Protoporphyrin IX modiﬁed (579.80 Da) appears only when
the ferritin is incubated with haemin and not when the ferritin,
the haemin and the protoporphyrin IX are alone.
We analysed commercial haemin in a solution of CH3CN/
H2O (50/50 v/v)/1% HCOOH at several concentrations, the
detection limit was determined to be lower than 107 mol/l
(Fig. 2a). The observed charge state is 1+, and is due to Fe(III)
and two negative charges on the porphyrin cycle; the monoiso-
topic mass is 616.2 Da. Fig. 2b shows the Electrospray mass
spectrum (ESI-MS) of haemin at 106 mol/l, this is in perfect
agreement with a theoretical spectrum established by isotopic
simulation (C34H32N4O4Fe) in Fig. 2a.
To be sure that it is not modiﬁed by itself, we stocked a solu-
tion of haemin for 4 months at room temperature at a dark
place and analyzed it again (Fig. 2c). The spectrum is identical
to the one of the fresh solution in Fig. 2b. This means that hae-
min in CH3CN/H2O (50/50 v/v)/1% HCOOH solution is stable
for several months and that haemin without ferritin does not
generate the signal at 579.80 Da.800
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Fig. 3. Control experiment with PPIX in CH3CN/H20 (50/50 v/v) + 1%HCOOH: (a) isotopic simulation of protonated PPIX
(C34H34N4O4 + H
+) = theoretical spectrum; (b) fresh solution; (c) solution stocked at room temperature for 4 months. The insets are zooms in
the m/z region of PPIX and show the isotopic proﬁles.
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Fig. 4. Control experiment with recombinant ferritin in CH3CN/H20 (50/50 v/v) + 1%HCOOH: (a) fresh solution; (b) solution stocked at room
temperature for 1 month. The insets are zooms in the m/z region of PPIX and haemin.
6278 N. de Val et al. / FEBS Letters 580 (2006) 6275–6280The same experiment was conducted with commercial
Protoporphyrin IX (PPIX) under the same conditions as
haemin. PPIX is stable for at least 4 months and both spectra
are in excellent agreement with isotopical simulation
(C34H34N4O4+H
+), Fig. 3. PPIX is present in solution in its
protonated form, the monoisotopic mass is 563.3 Da. This re-
sult means that PPIX does not produce the signal at 579.80 Da.
Finally, another experiment with recombinant ferritin with-
out any addition of haemin or PPIX provided evidence that
the protein itself does not generate fragments at low m/z values
during incubation, Fig. 4. A fresh solution of 106 mol/l was
analyzed and then kept for 1 month at room temperature in
a dark place and analyzed again. After this experiment, we
can demonstrate that ferritin does not produce the signal at
579.80 Da and that ferritin is a very stable protein (no degra-
dation after a long period of time).3.2. Ferritin incubated with haemin/PPIX
Ferritin was incubated with haemin and with PPIX in order
to get some information if the protein modiﬁes these molecules
over a period of 15 days to 12 months.
It was veriﬁed by ESI-MS that haemin/PPIX are eﬀectively
inserted into the protein: incubated ferritin was dialysed, all
the small molecules pass the membrane and only intact protein
is retained. After denaturation, haemin/PPIX was detected in
the protein solution, whereas in the dialysate no haemin/PPIX
could be detected.
That the ferritin molecule was in its intact tetracosahedric
form was demonstrated with several techniques: X-ray diﬀrac-
tion, by size exclusion chromatography and by mass spectrom-
etry in non-denaturating conditions.
Size exclusion chromatography was carried out on a Supe-
rose 6PC, 30 cm · 3,2 mm column, in 20 mM NH4HCO3,
6000 8000 10000 12000 14000
0
100
%
m/z
Fig. 5. ESI-MS spectrum of native ferritin in non-denaturating
conditions. The signals observed in the region of 10000 m/z correspond
to the complex with 24 subunits. Ferritin solution was prepared at
40 lmol/l, in 100 mmol/l pyridinium acetate. The measured mass is
491.469 ± 244 Da.
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proteins, the molecular weight of the native and the mutant
ferritin could be estimated to be about 480 kDa, corresponding
to the complex with 24 subunits.
ESI-MS in non-denaturating conditions after desalting of
the protein indicated the molecular weight to be
491.469 ± 244 Da, Fig. 5. This high error is due to the low sig-
nal obtained in the spectra, and this might be due to a statisti-
cal variation in the number of haemin/PPIX molecules inserted
into the ferritin. This large error does not allow us to conclude
on the presence or not of PPIX/haemin in the protein, but
there is no ambiguity that the measured mass corresponds to
the ferritin complex with 24 subunits.
High performance liquid chromatography coupled to ESI-
MS (HPLC-MS) allowed to conﬁrm that the mutant form of
ferritin is correctly mutated: Reversed phase C8 column was
used, with a gradient water/acetonitrile, 1 nmol was injected.400 600 800
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Fig. 6. Ferritin incubated with haemin in CH3CN/H20 (50/50 v/v) + 1%H
apoferritin; (b) solution stocked for 12 months, 8 molecules of haemin/apofer
zooms and in (b) additionally a simulation of the hydroxylated dimer (C34HFour Glu were muted to 4 Gln, and this corresponds to a mass
diﬀerence of 4 Da for 1 subunit. This mass diﬀerence was pre-
cisely observed, and allows to conclude that the mutant form is
modiﬁed in the supposed way. Some other forms were also ob-
served, with a mass shift of 16 Da, and this corresponds to the
mass diﬀerence expected for oxidation.
Diﬀerent solutions of apoferritin were incubated with PPIX
and haemin, diﬀerent pH conditions were used: pH 8
(NH4HCO3 0.1 M) and pH 5 (pyridinium acetate 0.1 M). Vol-
atile buﬀers were used because metal salt containing buﬀers are
not compatible with ESI-MS.
At Fig. 6 we present the results obtained with wild type fer-
ritin incubated with haemin in 100 mM NH4HCO3 buﬀer for
15 days and for 12 months (we obtained the same results with
the wild type ferritin at pH 5 and with the mutant ferritin
(E53,56,57,60Q) at pH 8 and 5). After incubation, the protein
was diluted in CH3CN/H2O (50/50 v/v) 1% HCOOH to release
the incorporated haemin and then analyzed by ESI-MS. The
spectrum taken after 15 days shows a strong signal of haemin,
whereas in the spectrum after 12 months, this signal has almost
disappeared. A doubly charged signal could be detected at 579
m/z, which might correspond to protonated, doubly hydroxyl-
ated protoporphyrin IX. The isotopical simulation is in perfect
agreement with this hypothesis.4. Discussions
The recombinant wild type horse L-chain apoferritin and its
mutant (E 53,56,57,60 Q) have the ability to incorporate and
to demetallate haemin to give the hydroxyethyl protoporphy-
rin IX derivative in a dimeric form (Fig. 7) in acidic and basic
conditions and after diﬀerent times of incubation with haemin
(Fig. 8).
The demetallation is faster at acid pH than basic pH. This
would have important biological consequences, since we know
that ferritin is progressively transformed to haemosiderin with-
in the acidic lysosomal compartment.1000 1200
b
t=12 months
t=15 days
a
m/z
COOH: (a) solution stocked for 15 days, 12 molecules of haemin/
ritin. All solutions were stocked at room temperature. The insets show
34N4O4OH)2 + H
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RCH2
R
H2C
R
R
OH
HO
+
2 OH
Fig. 7. Formation of hydroxyethyl protoporphyrin IX derivative
dimere form.
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Fig. 8. Intensity of haemin and modiﬁed haemin after diﬀerent times
of incubation with recombinant Horse L-chain apoferritin.
6280 N. de Val et al. / FEBS Letters 580 (2006) 6275–6280The ﬁrst hypothesis to explain the demetallation implicated
the four glutamates situated at the entrance of the hydropho-
bic pocket. From the present study, we conclude that, while
these four glutamates are important – demetallation is faster
in the wild type than the mutant – nonetheless their mutation
does not stop the incorporation and demetallation of haemin.
This suggests that another component of the protein, perhaps
arginine 59, which is also located in the hydrophobic pocket,
may also be involved.
We are currently constructing two new mutants: R59M and
E53,56,57,60Q/R59M to verify the importance of arginine 59
in this process.
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